Iguana Healthcare Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Iguana Healthcare Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3.7M	Buy	70,000 +10,000	+17%	+$583K	2.43%	10
2017 Q4	$4.08M	Sell	60,000 -20,000	-25%	-$1.4M	2.66%	12
2017 Q3	$6.59M	Buy	80,000 +5,000	+7%	+$396K	3.59%	4
2017 Q2	$7.02M	Buy	75,000 +25,000	+50%	+$1.53M	3.97%	3
2017 Q1	$3.18M	Sell	50,000 -25,000	-33%	-$1.52M	1.57%	19
2016 Q4	$3.33M	Sell	75,000 -575,000	-88%	-$20.2M	1.99%	18
2016 Q3	$23.4M	Buy	650,000 +560,000	+622%	+$12M	4.18%	2
2016 Q2	$1.24M	Buy	+90,000	New	+$1.32M	0.5%	64

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Iguana Healthcare Management's CLVS Position: Q1 2018 in Review

Iguana Healthcare Management increased its Clovis Oncology, Inc. (CLVS) stake by 17% in Q1 2018, buying an estimated $583K and bringing the position to 70,000 shares worth $3.7M. The position accounts for 2.43% of the portfolio, ranked #10.

Iguana Healthcare Management first reported a position in CLVS in Q2 2016 and has held it in 8 quarters since. The position peaked at $23.4M in Q3 2016. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2018.

Iguana Healthcare Management held 70,000 shares of Clovis Oncology, Inc. worth $3.7M as of Q1 2018.
Iguana Healthcare Management bought 10,000 Clovis Oncology, Inc. shares in Q1 2018, an estimated $583K.
Clovis Oncology, Inc. made up 2.43% of Iguana Healthcare Management's portfolio in Q1 2018, its #10 holding.
Iguana Healthcare Management first reported a position in Clovis Oncology, Inc. in Q2 2016 and has held it in 8 quarters since.
Iguana Healthcare Management's Clovis Oncology, Inc. position peaked at $23.4M in Q3 2016.
229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.